Three things to know:
1. The company plans to use the funds to accelerate the launch of its Zap-X surgical robot for the treatment of brain cancer and other disorders.
2. Zap-X provides image-guided stereotactic radiosurgery for tumors, lesions and conditions of the brain, head and neck, according to the company’s website.
3. More than $160 million has been raised by Zap Surgical in financing capital since it was founded in 2014.
More articles on devices:
Dr. Bryan Little appointed to state medical board, task force
Former Medtronic, Bioventus executive becomes CEO at BlueWind Medical
Exactech co-founders retire, current CEO to transition to board role — 4 insights
